M.D. Hazenberg MD PhD publications

foto

Publications MD PhD M.D. Hazenberg

Position
Medical Specialist
Main activities
Patient care, Research
Specialisation
Allogeneic hematopoietic stem cell transplantation; clinical care and research
Focus of research

Allogeneic hematopoietic stem cell transplantation and tumor immunology

2021

  • Epstein Joel B., Raber-Durlacher Judith E., Epstein Geena L., Hazenberg Mette D., Tzachanis Dimitrios, Spielberger Ricardo T. Chronic oral graft-versus-host disease: induction and maintenance therapy with photobiomodulation therapy Supportive care in cancer 2021;29 (3):1387-1394 [PubMed]
  • van Leeuwen S. J. M., Proctor G. B., Laheij A. M. G. A., Potting C. M. J., Smits O., Bronkhorst E. M., Hazenberg M. D., Haverman T. M., Brennan M. T., von Bültzingslöwen I., Raber-Durlacher J. E., Huysmans M. C. D. N. J. M., Rozema F. R., Blijlevens N. M. A. Significant salivary changes in relation to oral mucositis following autologous hematopoietic stem cell transplantation Bone marrow transplantation 2021 [PubMed]

2020

  • van Lier Yannouck F., de Bree Godelieve J., Jonkers René E., Roelofs Joris J. T. H., ten Berge Ineke J. M., Rutten Caroline E., Nur Erfan, Kuijpers Taco W., Hazenberg Mette D., Zeerleder Sacha S. Allogeneic hematopoietic cell transplantation in the management of GATA2 deficiency and pulmonary alveolar proteinosis Clinical immunology (Orlando, Fla.) 2020;218 [PubMed]
  • Voermans Carlijn, Hazenberg Mette D. Cellular therapies for graft-versus-host disease: a tale of tissue repair and tolerance Blood 2020;136 (4):410-417 [PubMed]
  • van Lier Yannouck F., Davids Mark, Haverkate Nienke J. E., de Groot Pieter F., Donker Marjolein L., Meijer Ellen, Heubel-Moenen Floor C. J. I., Nur Erfan, Zeerleder Sacha S., Nieuwdorp Max, Blom Bianca, Hazenberg Mette D. Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients Science translational medicine 2020;12 (556) [PubMed]
  • van der Wagen Lotte E., Miranda-Bedate Alberto, Janssen Anke, Fernando Febilla, Appukudige Nagesha, van Dooremalen Sanne, Westinga Kasper, Admiraal Rick, Lorenowicz Magdalena J., Huls Gerwin, Janssen Jeroen J. W. M., Broers Annoek E. C., van der Velden Walter J. F. M., van Marwijk Kooy Rien, Hazenberg Mette D., de Haar Colin, Lindemans Caroline, Jan Boelens Jaap, Kuball J. rgen Efficacy of MSC for steroid-refractory acute GVHD associates with MSC donor age and a defined molecular profile Bone marrow transplantation 2020 [PubMed]
  • Omar Saïd Z., Blom Bianca, Hazenberg Mette D. Innate lymphoid cells in treatment-induced gastrointestinal pathogenesis Current opinion in supportive and palliative care 2020;14 (2):135-141 [PubMed]
  • de Jong G., Bartels L., Kedde M., Verdegaal E. M. E., Gillissen M. A., Levie S. E., Cercel M. G., van Hal-van Veen S. E., Fatmawati C., van de Berg D., Yasuda E., Claassen Y. B., Bakker A. Q., van der Burg S. H., Schotte R., Villaudy J., Spits H., Hazenberg M. D., van Helden P. M., Wagner K. Melanoma cells can be eliminated by sialylated CD43 × CD3 bispecific T cell engager formats in vitro and in vivo Cancer immunology, immunotherapy 2020 [PubMed]
  • Haverman Thijs M., Raber-Durlacher Judith E., Raghoebar Iva I., Rademacher Willem M. H., Rozema Frederik R., Hazenberg Mette D., Epstein Joel B., Treister Nathaniel S. Oral chronic graft-versus-host disease: What the general dental practitioner needs to know Journal of the American Dental Association (1939) 2020;151 (11):846-856 [PubMed]

2019

  • Bartels Lina, de Jong Greta, Gillissen Marijn A., Yasuda Etsuko, Kattler Veronika, Bru Camille, Fatmawati Christien, van Hal-van Veen Susan E., Cercel Madalina G., Moiset Gemma, Bakker Arjen Q., van Helden Pauline M., Villaudy Julien, Hazenberg Mette D., Spits Hergen, Wagner Koen A chemo-enzymatically linked bispecific antibody retargets T cells to a sialylated epitope on CD43 in acute myeloid leukemia Cancer research 2019;79 (13):3372-3382 [PubMed]
  • Wardill H. R., Secombe K. R., Bryant R. V., Hazenberg M. D., Costello S. P. Adjunctive fecal microbiota transplantation in supportive oncology: Emerging indications and considerations in immunocompromised patients EBioMedicine 2019;44:730-740 [PubMed]
  • Garcia Garrido Hannah M, van Aalst Mariëlle, Schinkel Janke, Koen Gerrit, Defoer Jacqueline M, Hazenberg Mette D, Nur Erfan, Grobusch Martin P, Zeerleder Sascha S, Goorhuis Abraham, de Bree Godelieve J Early loss of immunity against measles following allogeneic hematopoietic stem cell transplantation American journal of hematology 2019;94 (10):E270-E272 [PubMed]
  • Hazenberg Mette D., Haverkate Nienke J. E., van Lier Yannouck F., Spits Hergen, Krabbendam Lisette, Bemelman Willem A., Buskens Christianne J., Blom Bianca, Shikhagaie Medya M. Human ectoenzyme-expressing ILC3: Immunosuppressive innate cells that are depleted in graft-versus-host disease Blood advances 2019;3 (22):3650-3660 [PubMed]
  • Blom Bianca, van Hoeven Vera, Hazenberg Mette D. ILCs in hematologic malignancies: Tumor cell killers and tissue healers Seminars in immunology 2019;41:101279 [PubMed]
  • Langedijk Annefleur C., van Aalst Mariëlle, Meek Bob, van Leeuwen Ester M. M., Zeerleder Sacha, Meijer Ellen, Hazenberg Mette D., Grobusch Martin P., Goorhuis Abraham Long-term pneumococcal vaccine immunogenicity following allogeneic hematopoietic stem cell transplantation Vaccine 2019;37 (3):510-515 [PubMed]
  • Laheij Alexa M. G. A., Raber-Durlacher Judith E., Koppelmans Renée G. A., Huysmans Marie-Charlotte D. N. J. M., Potting Carin, van Leeuwen Stephanie J. M., Hazenberg Mette D., Brennan Michael T., von Bültzingslöwen Inger, Johansson Jan-Erik, de Soet Johannes J., Haverman Thijs M., Buijs Mark J., Brandt Bernd W., Rozema Frederik R., Blijlevens Nicole M. A., Zaura Egija Microbial changes in relation to oral mucositis in autologous hematopoietic stem cell transplantation recipients Scientific reports 2019;9 (1) [PubMed]
  • de Jong Greta, Janssen Jeroen J. W. M., Biemond Bart J., Zeerleder Sacha S., Ossenkoppele Gert J., Visser Otto, Nur Erfan, Meijer Ellen, Hazenberg Mette D. Survival of early posthematopoietic stem cell transplantation relapse of myeloid malignancies European journal of haematology 2019;103 (5):491-499 [PubMed]
  • Schuster Stephen J., Bishop Michael R., Tam Constantine S., Waller Edmund K., Borchmann Peter, McGuirk Joseph P., Jäger Ulrich, Jaglowski Samantha, Andreadis Charalambos, Westin Jason R., Fleury Isabelle, Bachanova Veronika, Foley S. Ronan, Ho P. Joy, Mielke Stephan, Magenau John M., Holte Harald, Pantano Serafino, Pacaud Lida B., Awasthi Rakesh, Chu Jufen, Anak Özlem, Salles Gilles, Maziarz Richard T., Study group members AMC , Kersten Marie José J., Biemond Bart J., Burger Patrick, Claessen Marie-José J. A. G., Hazenberg Mette D., Kater Arnon P., Kemper E. M., Nur Erfan, Spiering Marjolein, Tonino Sanne H., Voermans Carlijn, Zeerleder Sacha S. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma New England journal of medicine 2019;380 (1):45-56 [PubMed]

2018

  • Vlijm-Kievit Anniek, Jorna Nori G. E., Moll Etelka, Pajkrt Eva, Pals Steven T., Middeldorp Saskia, Biemond Bart J., Zeerleder Sacha S., Tio Marieke A., Kemper E. Marleen, Hazenberg Mette D. Acute lymphoblastic leukemia during the third trimester of pregnancy Leukemia & lymphoma 2018;59 (5):1274-1276 [PubMed]
  • Gillissen Marijn A. Allogeneic hematopoietic stem cell transplantation as immunotherapy: B lymphocytes versus leukemia 2018. 165p. ISBN 9789462338388. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Spits H.; Co-supervisor: Hazenberg M. D.)
  • Gillissen Marijn A., Kedde Martijn, Jong Greta de, Moiset Gemma, Yasuda Etsuko, Levie Sophie E., Bakker Arjen Q., Claassen Yvonne B., Wagner Koen, Böhne Martino, Hensbergen Paul J., Speijer Dave, van Helden Pauline M., Beaumont Tim, Spits Hergen, Hazenberg Mette D. AML-specific cytotoxic antibodies in patients with durable graft-versus-leukemia responses Blood 2018;131 (1):131-143 [PubMed]
  • van Hoeven Vera, Munneke J. Marius, Cornelissen Anne S., Omar Said Z., Spruit Melchior J., Kleijer Marion, Bernink Jochem H., Blom Bianca, Voermans Carlijn, Hazenberg Mette D. Mesenchymal stromal cells stimulate the proliferation and IL-22 production of group 3 innate lymphoid cells Journal of immunology (Baltimore, Md. 2018;201 (4):1165-1173 [PubMed]
  • Hengeveld Paul J., Hazenberg Mette D., Biezeveld Maarten H., Raphael Martine F. Risico op trombose bij reactieve trombocytose Nederlands tijdschrift voor geneeskunde 2018;162 (41) [PubMed]
  • Hazenberg Mette D Stool can soften GVHD Blood 2018;132 (23):2429-2430 [PubMed]

2017

  • Willemse S. B., Bezuur D. L., Blom P., Kneppers E., Verheij J., Zaaijer H. L., Hazenberg M. D. Hepatitis E virus infection and hepatic GvHD in allogeneic hematopoietic stem cell transplantation recipients Bone marrow transplantation 2017;52 (4):622-624 [PubMed]
  • Gillissen Marijn A., de Jong Greta, Kedde Martijn, Yasuda Etsuko, Levie Sophie E., Moiset Gemma, Hensbergen Paul J., Bakker Arjen Q., Wagner Koen, Villaudy Jullien, van Helden Pauline M., Spits Hergen, Hazenberg Mette D. Patient-derived antibody recognizes a unique CD43 epitope expressed on all AML and has antileukemia activity in mice Blood advances 2017;1 (19):1551-1564 [PubMed]

2016

  • Gillissen M. A., de Jong G., Levie S. E., Yasuda E., Bakker A. Q., Evers L. M., Pals S. T., Huisman C., van Helden P. M., Spits H., Hazenberg M. D. AML relapse after rituximab treatment for GvHD: crucial role for B cells in GvL responses Bone marrow transplantation 2016;51 (9):1245-1248 [PubMed]
  • de Weerdt Iris, van Hoeven Vera, Munneke J. Marius, Endstra Sanne, Hofland Tom, Hazenberg Mette D., Kater Arnon P. Innate lymphoid cells are expanded and functionally altered in chronic lymphocytic leukemia Haematologica 2016;101 (11):e461-e464 [PubMed]
  • Munneke J. Marius Innate lymphoid cells in inflammation and repair 2016. 184p. ISBN 9789402801880. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Spits H., van Oers M. H. J.; Co-supervisor: Hazenberg M. D.)
  • Drylewicz Julia, Vrisekoop Nienke, Mugwagwa Tendai, de Boer Anne Bregje, Otto Sigrid A., Hazenberg Mette D., Tesselaar Kiki, de Boer Rob J., Borghans José A. M. Reconciling Longitudinal Naive T-Cell and TREC Dynamics during HIV-1 Infection PLoS ONE 2016;11 (3):e0152513 [PubMed]
  • Heijink D. M., Kater A. P., Hazenberg M. D., Hagenbeek A., Kersten M. J. T-cells fighting B-cell lymphoproliferative malignancies: the emerging field of CD19 CAR T-cell therapy Netherlands journal of medicine 2016;74 (4):147-151 [PubMed]
  • Gillissen M. A., Yasuda E., de Jong G., Levie S. E., Go D., Spits H., van Helden P. M., Hazenberg M. D. The modified FACS calcein AM retention assay: A high throughput flow cytometer based method to measure cytotoxicity Journal of immunological methods 2016;434:16-23 [PubMed]
  • Munneke J. Marius, Spruit Melchior J. A., Cornelissen Anne S., van Hoeven Vera, Voermans Carlijn, Hazenberg Mette D. The Potential of Mesenchymal Stromal Cells as Treatment for Severe Steroid-Refractory Acute Graft-Versus-Host Disease: A Critical Review of the Literature Transplantation 2016;100 (11):2309-2314 [PubMed]

2015

  • Munneke J. Marius, Hazenberg Mette D. Aangeboren lymfoïde cellen: innate lymphoid cells (ILCs) Nederlands tijdschrift voor hematologie 2015;12:166-172
  • Ladell Kristin, Hazenberg Mette D., Fitch Mark, Emson Claire, McEvoy-Hein Asgarian Bridget K., Mold Jeff E., Miller Corey, Busch Robert, Price David A., Hellerstein Marc K., McCune Joseph M. Continuous Antigenic Stimulation of DO11.10 TCR Transgenic Mice in the Presence or Absence of IL-1 beta: Possible Implications for Mechanisms of T Cell Depletion in HIV Disease Journal of immunology (Baltimore, Md. 2015;195 (9):4096-4105 [PubMed]
  • Bernink Jochem H., Krabbendam Lisette, Germar Kristine, de Jong Esther, Gronke Konrad, Kofoed-Nielsen Michael, Munneke J. Marius, Hazenberg Mette D., Villaudy Julien, Buskens Christianne J., Bemelman Willem A., Diefenbach Andreas, Blom Bianca, Spits Hergen Interleukin-12 and -23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria Immunity 2015;43 (1):146-160 [PubMed]

2014

  • Munneke J. Marius, Björklund Andreas T., Mjösberg Jenny M., Garming-Legert Karin, Bernink Jochem H., Blom Bianca, Huisman Cynthia, van Oers Marinus H. J., Spits Hergen, Malmberg Karl-Johan, Hazenberg Mette D. Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease Blood 2014;124 (5):812-821 [PubMed]
  • Teunissen Marcel B. M., Munneke J. Marius, Bernink Jochem H., Spuls Phyllis I., Res Pieter C. M., te Velde Anje, Cheuk Stanley, Brouwer Marijke W. D., Menting Stef P., Eidsmo Liv, Spits Hergen, Hazenberg Mette D., Mjösberg Jenny Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients Journal of investigative dermatology 2014;134 (9):2351-2360 [PubMed]
  • Hazenberg Mette D., Spits Hergen Human innate lymphoid cells Blood 2014;124 (5):700-709 [PubMed]
  • Haverman T. M., Raber-Durlacher J. E., Rademacher W. M. H., Vokurka S., Epstein J. B., Huisman C., Hazenberg M. D., de Soet J. J., de Lange J., Rozema F. R. Oral complications in hematopoietic stem cell recipients: the role of inflammation Mediators of inflammation 2014;2014:378281 [PubMed]

2013

  • Miedema Frank, Hazenberg Mette D., Tesselaar Kiki, van Baarle Debbie, de Boer Rob J., Borghans José A. M. Immune activation and collateral damage in AIDS pathogenesis Frontiers in immunology 2013;4 (4):UNSP 298 [PubMed]
  • Gentek Rebecca, Munneke J. Marius, Helbig Christina, Blom Bianca, Hazenberg Mette D., Spits Hergen, Amsen Derk Modulation of signal strength switches Notch from an inducer of T cells to an inducer of ILC2 Frontiers in immunology 2013;4:UNSP 334 [PubMed]

2012

  • Choi G., Meijer S. L., Hazenberg M. D. Disseminated bread yeast fungaemia in a baker's wife with acute myeloid leukaemia British journal of haematology 2012;158 (3):298 [PubMed]
  • Kwakernaak A. J., Hazenberg M. D., Roelofs J. J., van Noesel C. J., van Oers M. H., van Tellingen A. T-lymfoblastair lymfoom zich presenterend als primair renaal lymfoom met acute nierinsufficiëntie Nederlands tijdschrift voor hematologie 2012;9:34

2011

  • Hazenberg M. D., Biemond B. J., Pals S. T., Zumpolle C. M., Schinkel C. J., Linthorst G. E., Hoekstra J. B. L., Vos J. M. I. Clinical pathological conference: a non-Hodgkin's lymphoma patient with persistent anaemia after chemotherapy Netherlands journal of medicine 2011;69 (10):469-473 [PubMed]
  • Kuijpers Taco W., Ijspeert Hanna, van Leeuwen Ester M. M., Jansen Machiel H., Hazenberg Mette D., Weijer Kees C., van Lier Rene A. W., van der Burg Mirjam Idiopathic CD4(+) T lymphopenia without autoimmunity or granulomatous disease in the slipstream of RAG mutations Blood 2011;117 (22):5892-5896 [PubMed]
  • Kwakernaak Arjan J., Hazenberg Mette D., Roelofs Joris J. T. H., van Noesel Carel J. M., van Oers Marinus H. J., van Tellingen Anne Precursor T-lymphoblastic lymphoma presenting as primary renal lymphoma with acute renal failure NDT Plus 2011;4 (5):289-291 [PubMed]

2010

  • Cherpanath T. G. V., Nieuwdorp M., Hazenberg M. D., van Eeden S., van der Sluijs A. F. Large nocturnal eyes causing gastrointestinal bleeding in asymptomatic multiple myeloma. CMV enterocolitis Netherlands journal of medicine 2010;68 (10):324-327 [PubMed]

2008

  • Vrisekoop Nienke, den Braber Ineke, de Boer Anne Bregje, Ruiter An F. C., Ackermans Mariëtte T., van der Crabben Saskia N., Schrijver Elise H. R., Spierenburg Gerrit, Sauerwein Hans P., Hazenberg Mette D., de Boer Rob J., Miedema Frank, Borghans José A. M., Tesselaar Kiki Sparse production but preferential incorporation of recently produced naive T cells in the human peripheral pool Proceedings of the National Academy of Sciences of the United States of America 2008;105 (16):6115-6120 [PubMed]

2006

  • Borghans José A., Bredius Robbert G., Hazenberg Mette D., Roelofs Helene, Jol-van der Zijde Els C., Heidt Jeroen, Otto Sigrid A., Kuijpers Taco W., Fibbe Willem E., Vossen Jaak M., Miedema Frank, van Tol Maarten J. Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiency Blood 2006;108 (2):763-769 [PubMed]
  • Ribeiro Ruy M., Hazenberg Mette D., Perelson Alan S., Davenport Miles P. Naïve and memory cell turnover as drivers of CCR5-to-CXCR4 tropism switch in human immunodeficiency virus type 1: implications for therapy Journal of virology 2006;80 (2):802-809 [PubMed]

2005

  • Borghans José A. M., Hazenberg Mette D., Miedema Frank Limited role for the thymus in SIV pathogenesis European journal of immunology 2005;35 (1):42-45 [PubMed]
  • Koning Fransje A., Otto Sigrid A., Hazenberg Mette D., Dekker Linda, Prins Maria, Miedema Frank, Schuitemaker Hanneke Low-level CD4(+) T cell activation is associated with low susceptibility to HIV-1 infection Journal of immunology (Baltimore, Md. 2005;175 (9):6117-6122 [PubMed]
  • Harris Jeffrey M., Hazenberg Mette D., Poulin Jean-François, Higuera-Alhino Dana, Schmidt Diane, Gotway Michael, McCune Joseph M. Multiparameter evaluation of human thymic function: interpretations and caveats Clinical immunology (Orlando, Fla.) 2005;115 (2):138-146 [PubMed]

2004

  • Hazenberg Mette D., Otto Sigrid A., van Rossum Annemarie M. C., Scherpbier Henriëtte J., de Groot Ronald, Kuijpers Taco W., Lange Joep M. A., Hamann Dörte, de Boer Rob J., Borghans José A. M., Miedema Frank Establishment of the CD4(+) T-cell pool in healthy children and untreated children infected with HIV-1 Blood 2004;104 (12):3513-3519 [PubMed]
  • van Asten Liselotte, Danisman Figen, Otto Sigrid A., Borghans José A. M., Hazenberg Mette D., Coutinho Roel A., Prins Maria, Miedema Frank Pre-seroconversion immune status predicts the rate of CD4 T cell decline following HIV infection AIDS (London, England) 2004;18 (14):1885-1893 [PubMed]

2003

  • Hazenberg Mette D., Otto Sigrid A., Hamann Dörte, Roos Marijke Th L., Schuitemaker Hanneke, de Boer Rob J., Miedema Frank Depletion of naive CD4 T cells by CXCR4-using HIV-1 variants occurs mainly through increased T-cell death and activation AIDS (London, England) 2003;17 (10):1419-1424 [PubMed]
  • van Rij Ronald P., Hazenberg Mette D., van Benthem Birgit H. B., Otto Sigrid A., Prins Maria, Miedema Frank, Schuitemaker Hanneke Early viral load and CD4(+) T cell count, but not percentage of CCR5(+) or CXCR4(+) CD4(+) T cells, are associated with R5-to-X4 HIV type 1 virus evolution AIDS research and human retroviruses 2003;19 (5):389-398 [PubMed]
  • Hazenberg Mette D., Otto Sigrid A., van Benthem Birgit H. B., Roos Marijke Th L., Coutinho Roel A., Lange Joep M. A., Hamann Dörte, Prins Maria, Miedema Frank Persistent immune activation in HIV-1 infection is associated with progression to AIDS AIDS (London, England) 2003;17 (13):1881-1888 [PubMed]
  • Hazenberg Mette D., Borghans José A. M., de Boer Rob J., Miedema Frank Thymic output: a bad TREC record Nature immunology 2003;4 (2):97-99 [PubMed]

2002

  • Davenport Miles P., Zaunders John J., Hazenberg Mette D., Schuitemaker Hanneke, van Rij Ronald P. Cell turnover and cell tropism in HIV-1 infection Trends in microbiology 2002;10 (6):275-278 [PubMed]
  • Hazenberg Mette D., Otto Sigrid A., Wit Ferdinand W. N. M., Lange Joep M. A., Hamann Dörte, Miedema Frank Discordant responses during antiretroviral therapy role of immune activation and T cell redistribution rather than true CD4 T cell loss AIDS (London, England) 2002;16 (9):1287-1289 [PubMed]
  • van der Vliet Hans J. J., von Blomberg B. Mary E., Hazenberg Mette D., Nishi Nobusuke, Otto Sigrid A., van Benthem Birgit H., Prins Maria, Claessen Frans A., van den Eertwegh Alfons J. M., Giaccone Giuseppe, Miedema Frank, Scheper Rik J., Pinedo Herbert M. Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection Journal of immunology (Baltimore, Md. 2002;168 (3):1490-1495 [PubMed]
  • Hazenberg Mette D., Otto Sigrid A., de Pauw Elmar S., Roelofs Helene, Fibbe Willem E., Hamann Dörte, Miedema Frank T-cell receptor excision circle and T-cell dynamics after allogeneic stem cell transplantation are related to clinical events Blood 2002;99 (9):3449-3453 [PubMed]
  • Hazenberg M. D. T cell turnover and thymic function in HIV-1 infection 2002. 207p. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Miedema F.; Co-supervisors: Hamann D., de Boer R. J.)
  • Hazenberg M. D. T-cell turnover during HIV infection AIDS reader 2002;12:S10-S13

2001

  • Hazenberg M. D., Verschuren M. C., Hamann D., Miedema F., van Dongen J. J. T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation Journal of molecular medicine (Berlin, Germany) 2001;79 (11):631-640 [PubMed]

2000

  • Hazenberg M. D., Otto S. A., Cohen Stuart J. W., Verschuren M. C., Borleffs J. C., Boucher C. A., Coutinho R. A., Lange J. M., Rinke de Wit T. F., Tsegaye A., van Dongen J. J., Hamann D., de Boer R. J., Miedema F. Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection Nature medicine 2000;6 (9):1036-1042 [PubMed]
  • Hazenberg M. D., Hamann D., Schuitemaker H., Miedema F. T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock Nature immunology 2000;1 (4):285-289 [PubMed]
  • Hazenberg M. D., Stuart J. W., Otto S. A., Borleffs J. C., Boucher C. A., de Boer R. J., Miedema F., Hamann D. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART) Blood 2000;95 (1):249-255 [PubMed]